What's new? Log in Free sign up

STERIS (STE) S-4Registration of securities issued in business combination transactions

Filed: 6 Nov 18, 6:31am

Exhibit 99.2

Consent of Director Nominee

October 22, 2018

Pursuant to Rule 438 under the Securities Act of 1933 (the “Securities Act”), in connection with the Registration Statement onForm S-4 (the “Registration Statement”) of STERIS Limited (the “Company”), the undersigned hereby consents to being named and described as a person who will become a director of the Company in the Registration Statement and any amendment or supplement to any prospectus included in such Registration Statement, any amendment to such Registration Statement or any subsequent Registration Statement filed pursuant to Rule 462(b) under the Securities Act and to the filing or attachment of this consent with such Registration Statement and any amendment or supplement thereto.

[Signature page follows]

IN WITNESS WHEREOF, the undersigned has executed this consent as of the date first written above.

/s/ Loyal W. Wilson

Name: Loyal W. Wilson

Consent of Director Nominee

October 22, 2018

Pursuant to Rule 438 under the Securities Act of 1933 (the “Securities Act”), in connection with the Registration Statement onForm S-4 (the “Registration Statement”) of STERIS Limited (the “Company”), the undersigned hereby consents to being named and described as a person who will become a director of the Company in the Registration Statement and any amendment or supplement to any prospectus included in such Registration Statement, any amendment to such Registration Statement or any subsequent Registration Statement filed pursuant to Rule 462(b) under the Securities Act and to the filing or attachment of this consent with such Registration Statement and any amendment or supplement thereto.

[Signature page follows]

IN WITNESS WHEREOF, the undersigned has executed this consent as of the date first written above.

/s/ Michael B. Wood

Name: Michael B. Wood

Consent of Director Nominee

October 22, 2018

Pursuant to Rule 438 under the Securities Act of 1933 (the “Securities Act”), in connection with the Registration Statement onForm S-4 (the “Registration Statement”) of STERIS Limited (the “Company”), the undersigned hereby consents to being named and described as a person who will become a director of the Company in the Registration Statement and any amendment or supplement to any prospectus included in such Registration Statement, any amendment to such Registration Statement or any subsequent Registration Statement filed pursuant to Rule 462(b) under the Securities Act and to the filing or attachment of this consent with such Registration Statement and any amendment or supplement thereto.

[Signature page follows]

IN WITNESS WHEREOF, the undersigned has executed this consent as of the date first written above.

/s/ Richard M. Steeves

Name: Richard M. Steeves

Consent of Director Nominee

October 22, 2018

Pursuant to Rule 438 under the Securities Act of 1933 (the “Securities Act”), in connection with the Registration Statement onForm S-4 (the “Registration Statement”) of STERIS Limited (the “Company”), the undersigned hereby consents to being named and described as a person who will become a director of the Company in the Registration Statement and any amendment or supplement to any prospectus included in such Registration Statement, any amendment to such Registration Statement or any subsequent Registration Statement filed pursuant to Rule 462(b) under the Securities Act and to the filing or attachment of this consent with such Registration Statement and any amendment or supplement thereto.

[Signature page follows]

IN WITNESS WHEREOF, the undersigned has executed this consent as of the date first written above.

/s/ Mohsen M. Sohi

Name: Mohsen M. Sohi

Consent of Director Nominee

October 22, 2018

Pursuant to Rule 438 under the Securities Act of 1933 (the “Securities Act”), in connection with the Registration Statement onForm S-4 (the “Registration Statement”) of STERIS Limited (the “Company”), the undersigned hereby consents to being named and described as a person who will become a director of the Company in the Registration Statement and any amendment or supplement to any prospectus included in such Registration Statement, any amendment to such Registration Statement or any subsequent Registration Statement filed pursuant to Rule 462(b) under the Securities Act and to the filing or attachment of this consent with such Registration Statement and any amendment or supplement thereto.

[Signature page follows]

IN WITNESS WHEREOF, the undersigned has executed this consent as of the date first written above.

/s/ Nirav R. Shah

Name: Nirav R. Shah

Consent of Director Nominee

October 22, 2018

Pursuant to Rule 438 under the Securities Act of 1933 (the “Securities Act”), in connection with the Registration Statement onForm S-4 (the “Registration Statement”) of STERIS Limited (the “Company”), the undersigned hereby consents to being named and described as a person who will become a director of the Company in the Registration Statement and any amendment or supplement to any prospectus included in such Registration Statement, any amendment to such Registration Statement or any subsequent Registration Statement filed pursuant to Rule 462(b) under the Securities Act and to the filing or attachment of this consent with such Registration Statement and any amendment or supplement thereto.

[Signature page follows]

IN WITNESS WHEREOF, the undersigned has executed this consent as of the date first written above.

/s/ Walter M. Rosebrough, Jr.

Name: Walter M. Rosebrough, Jr.

Consent of Director Nominee

October 22, 2018

Pursuant to Rule 438 under the Securities Act of 1933 (the “Securities Act”), in connection with the Registration Statement onForm S-4 (the “Registration Statement”) of STERIS Limited (the “Company”), the undersigned hereby consents to being named and described as a person who will become a director of the Company in the Registration Statement and any amendment or supplement to any prospectus included in such Registration Statement, any amendment to such Registration Statement or any subsequent Registration Statement filed pursuant to Rule 462(b) under the Securities Act and to the filing or attachment of this consent with such Registration Statement and any amendment or supplement thereto.

[Signature page follows]

IN WITNESS WHEREOF, the undersigned has executed this consent as of the date first written above.

/s/ Sir Duncan K. Nichol

Name: Sir Duncan K. Nichol

Consent of Director Nominee

October 22, 2018

Pursuant to Rule 438 under the Securities Act of 1933 (the “Securities Act”), in connection with the Registration Statement onForm S-4 (the “Registration Statement”) of STERIS Limited (the “Company”), the undersigned hereby consents to being named and described as a person who will become a director of the Company in the Registration Statement and any amendment or supplement to any prospectus included in such Registration Statement, any amendment to such Registration Statement or any subsequent Registration Statement filed pursuant to Rule 462(b) under the Securities Act and to the filing or attachment of this consent with such Registration Statement and any amendment or supplement thereto.

[Signature page follows]

IN WITNESS WHEREOF, the undersigned has executed this consent as of the date first written above.

/s/ David B. Lewis

Name: David B. Lewis

Consent of Director Nominee

October 22, 2018

Pursuant to Rule 438 under the Securities Act of 1933 (the “Securities Act”), in connection with the Registration Statement onForm S-4 (the “Registration Statement”) of STERIS Limited (the “Company”), the undersigned hereby consents to being named and described as a person who will become a director of the Company in the Registration Statement and any amendment or supplement to any prospectus included in such Registration Statement, any amendment to such Registration Statement or any subsequent Registration Statement filed pursuant to Rule 462(b) under the Securities Act and to the filing or attachment of this consent with such Registration Statement and any amendment or supplement thereto.

[Signature page follows]

IN WITNESS WHEREOF, the undersigned has executed this consent as of the date first written above.

/s/ Jacqueline B. Kosecoff

Name: Jacqueline B. Kosecoff

Consent of Director Nominee

October 22, 2018

Pursuant to Rule 438 under the Securities Act of 1933 (the “Securities Act”), in connection with the Registration Statement onForm S-4 (the “Registration Statement”) of STERIS Limited (the “Company”), the undersigned hereby consents to being named and described as a person who will become a director of the Company in the Registration Statement and any amendment or supplement to any prospectus included in such Registration Statement, any amendment to such Registration Statement or any subsequent Registration Statement filed pursuant to Rule 462(b) under the Securities Act and to the filing or attachment of this consent with such Registration Statement and any amendment or supplement thereto.

[Signature page follows]

IN WITNESS WHEREOF, the undersigned has executed this consent as of the date first written above.

/s/ Richard C. Breeden

Name: Richard C. Breeden

Consent of Director Nomee

October 22, 2018

Pursuant to Rule 438 under the Securities Act of 1933 (the “Securities Act”), in connection with the Registration Statement onForm S-4 (the “Registration Statement”) of STERIS Limited (the “Company”), the undersigned hereby consents to being named and described as a person who will become a director of the Company in the Registration Statement and any amendment or supplement to any prospectus included in such Registration Statement, any amendment to such Registration Statement or any subsequent Registration Statement filed pursuant to Rule 462(b) under the Securities Act and to the filing or attachment of this consent with such Registration Statement and any amendment or supplement thereto.

[Signature page follows]

IN WITNESS WHEREOF, the undersigned has executed this consent as of the date first written above.

/s/ Cynthia L. Feldmann

Name: Cynthia L. Feldmann

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.